Today’s mostly paper-dependent clinical trials pose fundamental challenges to the pharmaceutical industry. Such trials can be prohibitively expensive, struggle to enroll and retain a sufficient number of participants, and have difficulty maintaining compliance and data reliability. But with the advent of virtual and partially virtual trials using digital tools and devices, we have the opportunity to substantially improve efficiency by deploying the same design principles that make consumer apps so successful.

The health system revenue cycle is a complex process, starting with registration and scheduling, and ending with claims submitted and processed and payments received. Removing bottlenecks that prevent faster receivables has been a constant challenge facing revenue cycle leaders. Missing providers in EHRs is a major root cause of bottlenecks and rework. The advent of promising new digital provider enrollment workflows may, someday soon, eliminate them.